Instructions for use of Mexidol, composition, release form, analogues, indications, contraindications

Release form and composition

The drug is available in several forms. Among them:

Pills
The dosage and form of the drug are selected individually by the attending physician. Mexidol tablets are available in a dosage of 125 mg. Indicated for oral administration. They have a round shape, the color of the shell can vary from white to cream. Available in packs of 30 and 50 pieces.
Active ingredient Mexidol: ethylmethylhydroxypyridine succinate 125 mg
Excipients: lactose monohydrate, sodium carmellose, magnesium stearate, talc, titanium dioxide, polyvinyl alcohol, macrogol polyethylene glycol.
Injection
The solution for injection is contained in ampoules of 2 and 5 ml. The package contains 5 pieces. The solution is odorless and colorless. A yellowish tint is allowed. The composition of Mexidol depends on the form of release.
Mexidol 50 mg/2ml
Read also: Prostatitis: symptoms and treatment of prostate inflammation in men
Active ingredient Mexidol: ethylmethylhydroxypyridine succinate 50 mg/2 ml. Excipients: sodium metabisulfite.
Mexidol 50 mg/5 ml
Active ingredient Mexidol: ethylmethylhydroxypyridine succinate 50 mg/5 ml. Excipients: sodium metabisulfite.
Toothpaste
Mexidol toothpaste is available in a 65 g tube. The color of the drug depends on the type of paste. It can be pink, transparent, light green, white. The entire line of Mexidol toothpaste has a mint flavor. Active ingredient of Mexidol: ethylmethylhydroxypyridine succinate 65 mg. Excipients: sorbitol, polyethylene glycol, titanium dioxide, silicon dioxide, demineralized water, xanthan gum, sodium lauryl sulfate.

Composition and release form

Active ingredient: ethylmethylhydroxypyridine succinate – 50 mg. Excipients: sodium metabisulfite – 0.4 mg; water for injections up to 1 ml. Solution for intravenous and intramuscular administration 50 mg/ml in colorless or light-protective glass ampoules with a blue break point or a white break point and three marking rings (top - yellow, middle - white, bottom - red) 2 ml or 5 ml . 5 ampoules in a blister pack. 1 or 2 blister packs along with instructions for medical use in a cardboard pack. 4, 10 or 20 blister packs along with instructions for medical use in a box of cardboard (for hospitals).

pharmachologic effect

The pharmacological effect of Mexidol is due to its antioxidant properties. The drug eliminates oxygen starvation of tissues, normalizes thinking and memory processes. The drug has a positive effect on the condition of blood vessels susceptible to atherosclerotic changes.

Pharmacodynamics

The drug has antihypoxic, nootropic, anticonvulsant, anxiolytic and stress-protective effects. Mexidol increases the body's resistance to damaging factors, including shock, oxygen starvation of tissues, alcohol intoxication, and cerebrovascular accident due to ischemia.

The drug helps improve blood circulation in the brain area, prevents blood thickening and thrombus formation.

Has antihypercholesterol effect. Reduces the concentration of total cholesterol and low-density lipoproteins.

Mexidol normalizes sleep processes, increases attention, and improves thought processes.

Taking the drug against the background of withdrawal syndrome helps reduce the manifestations of alcohol and neurotoxic intoxication, normalizes autonomic functions, and eliminates cognitive impairment.

The combined use of the drug Mexidol with tranquilizers, sleeping pills, antidepressants and anticonvulsants enhances the effect of the latter. This allows you to reduce the dosage of prescribed medications.

Pharmacokinetics

The drug is quickly absorbed. The maximum concentration is reached 45-50 minutes after administration. After entering the bloodstream, Mexidol is quickly distributed in organs and tissues. The drug stays in the body for about 4-5.5 hours, depending on the method of administration.

Metabolism of the drug occurs in the liver. Mexidol forms several metabolites and breaks down into components.

Excretion from the body is carried out with urine. Most of it is excreted in the form of metabolites, the rest unchanged. The half-life is approximately 2-3 hours.

Mexidol® (Mexidolum®)

Mexidol® is an inhibitor of free radical processes, a membrane protector with antihypoxic, stress-protective, nootropic, anticonvulsant and anxiolytic effects. The drug increases the body's resistance to the effects of various damaging factors (shock, hypoxia and ischemia, cerebrovascular accidents, intoxication with alcohol and antipsychotics (neuroleptics)).

The mechanism of action of Mexidol® is due to its antioxidant, antihypoxic and membrane protective effects. It inhibits lipid peroxidation, increases the activity of superoxide dismutase, increases the lipid-protein ratio, reduces membrane viscosity, and increases its fluidity. Mexidol® modulates the activity of membrane-bound enzymes (calcium-independent phosphodiesterase, adenylate cyclase, acetylcholinesterase),

Receptor complexes (benzodiazepine, GABA, acetylcholine), which enhances their ability to bind to ligands, helps preserve the structural and functional organization of biomembranes, transport of neurotransmitters and improve synaptic transmission. Mexidol® increases the content of dopamine in the brain. Causes an increase in compensatory activation of aerobic glycolysis and a decrease in the degree of inhibition in oxidative processes in the Krebs cycle. Under hypoxic conditions, with an increase in the content of ATP and creatine phosphate, activation of the energy-synthesizing functions of mitochondria, stabilization of cell membranes.

The drug improves metabolism and blood supply to the brain, improves microcirculation and rheological properties of blood, and reduces platelet aggregation. Stabilizes the membrane structures of blood cells; (erythrocytes and platelets) with hemolysis. It has a lipid-lowering effect, reduces the content of total cholesterol and low-density lipoproteins.

The anti-stress effect is manifested in the normalization of post-stress behavior, somatovegetative disorders, restoration of sleep-wake cycles, impaired learning and memory processes, reduction of dystrophic and morphological changes in various structures of the brain.

Mexidol® has a pronounced antitoxic effect in withdrawal symptoms. It eliminates the neurological and neurotoxic manifestations of acute alcohol intoxication, restores behavioral disorders, autonomic functions, and is also able to relieve cognitive impairment caused by long-term use of ethanol and its withdrawal. Under the influence of Mexidol®, the effect of tranquilizing, neuroleptic, antidepressant, hypnotics and anticonvulsants is enhanced, which makes it possible to reduce their doses and reduce side effects. Mexidol® improves the functional state of ischemic myocardium. In conditions of coronary insufficiency, it increases collateral blood supply to the ischemic myocardium, helps maintain the integrity of cardiomyocytes and maintain their functional activity. Effectively restores myocardial contractility in reversible cardiac dysfunction.

Indications for use

The following indications for use of Mexidol in the form of a solution are distinguished:

acute cerebrovascular accidents;
traumatic brain injuries;
manifestations of vegetative dystonia;
open-angle glaucoma;
anxiety and neurosis-like conditions;
withdrawal syndrome due to alcohol abuse;
drug intoxication;
hypertonic disease;
migraine-type headache;
myocardial infarction in the acute phase.

Mexidol is prescribed as part of complex therapy for acute purulent lesions of the abdominal cavity requiring surgical intervention. This is, for example, acute pancreatic necrosis, peritonitis.

Indications for the tablet form of the drug are:

consequences of cerebrovascular accidents;
mild form of traumatic brain injury, as well as consequences;
encephalopathy of various origins;
as part of complex therapy of diseases of the cardiovascular system;
asthenia;
long-term exposure to psycho-emotional factors.

Mexidol for VSD

The indication for the use of Mexidol injections is vegetative-vascular dystonia. The drug helps improve blood circulation. As a result, headaches and dizziness are relieved. The dosage is selected individually depending on the severity of symptoms.

Mexidol for hypertension

The drug is part of the complex therapy of arterial hypertension. Mexidol normalizes metabolic processes that take part in the functioning of the cardiovascular system. The drug improves blood circulation, helping to stabilize blood pressure.

Mexidol for panic attacks

The drug has antihypoxic, nootropic and stress-protective effects. As a result, brain activity normalizes and the severity of anxiety symptoms decreases.

Mexidol for epilepsy

The anticonvulsant effect of the drug allows its use in the complex treatment of epilepsy. Mexidol normalizes cerebral circulation, improves thinking and memory processes. The dosage is determined by the attending physician depending on the severity of the condition.

Mexidol for oncology

Mexidol is included in the complex therapy of oncopathologies due to its antioxidant effect. The decision about the need to prescribe the drug is made by the attending physician. Some tumor formations exclude the possibility of taking Mexidol.

Mexidol for migraines

The disease tends to periodically worsen. Mexidol is used to prevent migraine-type headaches. The drug improves blood microcirculation processes in the brain area.

Mexidol for stroke

Cerebrovascular accidents and their consequences are included in the list of indications for taking the drug. Mexidol is used both in the acute period and as a prevention of relapse. Indications for the use of the drug in tablets are preliminary injection therapy.

Mexidol for multiple sclerosis

Used as part of complex therapy. Improves cerebral circulation, helps normalize cognitive functions.

Mexidol, 10 pcs., 2 ml, 50 mg/ml, solution for intravenous and intramuscular administration

IV (stream or drip) or IM.

When administered by infusion, the drug should be diluted in an isotonic sodium chloride solution.

Mexidol® is administered slowly over 5–7 minutes in a stream, and dropwise at a rate of 40–60 drops per minute. The maximum daily dose should not exceed 1200 mg.

For acute cerebrovascular accidents

Mexidol® is used in the first 10-14 days - 200-500 mg IV drip 2-4 times a day, then - 200-250 mg IM 2-3 times a day for 2 weeks.

For TBI and consequences of TBI

- IV drip of 200–500 mg 2–4 times a day, for 10–15 days.

For dyscirculatory encephalopathy in the decompensation phase

Mexidol® should be administered intravenously in a stream or drip at a dose of 200–500 mg 1–2 times a day for 14 days. Then - IM 100-250 mg/day over the next 2 weeks.

For course prophylaxis of dyscirculatory encephalopathy

the drug is administered intramuscularly at a dose of 200–250 mg 2 times a day for 10–14 days.

For mild cognitive impairment in elderly patients and anxiety disorders

the drug is used intramuscularly at a daily dose of 100–300 mg/day for 14–30 days.

In acute myocardial infarction as part of complex therapy

Mexidol® is administered intravenously or intramuscularly for 14 days against the background of traditional therapy for myocardial infarction, including nitrates, β-blockers, ACE inhibitors, thrombolytics, anticoagulant and antiplatelet agents, as well as symptomatic agents according to indications. In the first 5 days, to achieve maximum effect, it is advisable to administer the drug intravenously; in the next 9 days, Mexidol® can be administered intramuscularly. The drug is administered intravenously by drip infusion, slowly (to avoid side effects) in an isotonic sodium chloride solution or 5% dextrose (glucose) solution in a volume of 100–150 ml for 30–90 minutes. If necessary, slow jet administration of the drug is possible, lasting at least 5 minutes.

The drug is administered (IV or IM) 3 times a day, every 8 hours. The daily therapeutic dose is 6–9 mg/kg/day, a single dose is 2–3 mg/kg. The maximum daily dose should not exceed 800 mg, single dose - 250 mg.

For open-angle glaucoma of various stages as part of complex therapy

Mexidol® is administered intramuscularly at 100–300 mg/day, 1–3 times a day for 14 days.

For alcohol withdrawal syndrome

Mexidol® is administered in a dose of 200–500 mg intravenously or intramuscularly 2–3 times a day for 5–7 days.

In case of acute intoxication with antipsychotic drugs

the drug is administered intravenously at a dose of 200–500 mg/day for 7–14 days.

In acute purulent-inflammatory processes in the abdominal cavity (acute necrotizing pancreatitis, peritonitis)

the drug is prescribed on the first day both in the preoperative and postoperative periods. The administered doses depend on the form and severity of the disease, the prevalence of the process, and variants of the clinical course. The drug should be discontinued gradually only after a stable positive clinical and laboratory effect.

For acute edematous (interstitial) pancreatitis

Mexidol® is prescribed 200–500 mg 3 times a day intravenously (in isotonic sodium chloride solution) and intramuscularly.
Mild severity of necrotizing pancreatitis
- 100–200 mg 3 times a day intravenously (in isotonic sodium chloride solution) and intramuscularly.
Moderate severity
- 200 mg 3 times a day intravenously (in isotonic sodium chloride solution).
Severe course
- in a pulse dosage of 800 mg on the first day, with a two-fold administration regimen;
then - 200–500 mg 2 times a day with a gradual reduction in the daily dose. Extremely severe course
- at an initial dosage of 800 mg/day until the manifestations of pancreatogenic shock are persistently relieved, upon stabilization of the condition - 300-500 mg 2 times a day intravenously (in isotonic sodium chloride solution) with a gradual decrease in the daily dosage.

Directions for use and doses

The method of administration and dosage of Mexidol are determined by the attending physician depending on the disease and the severity of the condition.

Mexidol 5

Solution for injection, 5 ml. Before use, the drug must be diluted with isotonic sodium chloride solution. When using the drug as a jet, it is administered within 5-7 minutes. Drip administration requires a speed of 40-60 drops per minute. The daily dose of the drug should not exceed 1200 mg.

Mexidol 10

The solution for injection contains 5 ampoules of 10 ml each. The contents are dissolved using isotonic saline solution. Used when a long course of therapy is necessary. The drug is administered intravenously or intramuscularly, depending on the pathology and severity of the condition. In case of acute cerebral circulation, intravenous administration of the drug is prescribed at a dosage of 200-500 mg 2-4 times a day, followed by intramuscular administration of 200-300 mg 2-3 times a day.

Mexidol 2

5 ampoules per package contain 2 ml of the drug. The solution is used for intramuscular or intravenous administration by stream or drip. The contents of the ampoule are diluted with isotonic saline solution. The dosage depends on the pathology for which the drug is prescribed. The average dose is 200-500 mg 2-3 times a day IV or IM.

Mexidol 125

The use of Mexidol in tablet form is indicated for various conditions. The dosage is 125-250 mg 3 times a day. The maximum permissible daily dose is 800 mg. The duration of the course is determined by the attending physician depending on the disease and severity of the condition. On average it ranges from 14 days to 1.5 months. The course begins with 1-2 tablets per day. The dose is gradually increased until the clinical effect of the drug is achieved. Abrupt discontinuation of the drug is unacceptable. The dosage is gradually reduced until complete withdrawal.

Mexidol tablets

Mexidol is available in tablet form. The dosage of the drug is 125 mg. The tablets are film-coated and are in cell packaging. Indications for the use of the tablet form of the drug Mexidol are the recovery period after an acute cerebrovascular accident, a mild form of traumatic brain injury, encephalopathy of various origins, VSD, and mild cognitive disorders. Mexidol in tablet form is used as a continuation of injection therapy.

Mexidol solution

The solution for injection is available in volumes of 2, 5 and 10 ml. It has no color. A yellowish tint of the solution is allowed. The contents of the ampoules are dissolved using an isotonic sodium chloride solution. The drug is used for the treatment of acute cerebrovascular accident, severe traumatic brain injury and its consequences, cognitive disorders, acute myocardial infarction, and reducing the severity of symptoms of withdrawal syndrome due to alcoholism. Mexidol in the form of a solution is prescribed for acute cerebrovascular accident, severe traumatic brain injury, and acute myocardial infarction.

The drug is used to reduce the severity of withdrawal symptoms due to excessive consumption of alcoholic beverages. The dosage of the drug is selected by the attending physician individually depending on the pathology.

Mexidol in ampoules

The drug is available in glass ampoules of 2 and 5 ml. The package contains from 5 to 10 ampoules. Mexidol is used for intramuscular or intravenous administration. To obtain the finished solution, the contents of the ampoule are diluted with an isotonic sodium chloride solution. Mexidol is administered in a stream or drip. The dosage and route of administration are determined by the attending physician depending on the disease and severity of the condition. The maximum dose of the drug is 1200 mg per day

Mexidol injections

The dosage and frequency of use of Mexidol in the form of injections is determined by the disease for which the drug is prescribed. In case of acute cerebrovascular accident, intravenous drip administration of the drug 2-4 times a day is indicated. The dosage is 200-500 mg. The medicine is then administered intramuscularly. A similar method is used to treat traumatic brain injuries.

To relieve cerebrovascular insufficiency, drip administration of 200-500 mg of the drug is used 1-2 times a day. The course is determined by the severity of symptoms.

In the presence of dyscirculatory encephalopathy, Mexidol is administered intramuscularly at a dose of 400-500 mg 2 times a day.

Age-related impairment of cognitive functions is treated by intramuscular administration of the drug in a dosage of 100-300 mg.

How to inject Mexidol

It is recommended to administer the drug intravenously during the first 5 days of therapy. Then the transition to intramuscular use is allowed. To prepare the solution, the contents of the ampoule are dissolved in an isotonic sodium chloride solution. In some cases, the use of a 5% glucose solution is indicated.

Injection of the drug is carried out within 5-7 minutes. The most suitable speed for drip use of the drug is 40-60 drops per minute. The maximum dosage is 1200 mg per day.

Mexidol Dent (toothpaste)

The drug is available in the form of toothpaste. The tube contains 65 g of product. Indications for the use of Mexidol Dent are inflammation and bleeding of the gums. The drug helps accelerate the regeneration of damaged oral mucosa and normalizes blood microcirculation. The toothpaste does not contain preservatives or dyes. Due to its composition, it does not disturb the microflora of the oral cavity. Mexidol Dent is indicated for long-term use. To use, simply apply a small amount of paste to your toothbrush. Use sweeping movements to process the teeth. The gums are gently massaged. The course of use of the drug is not limited.

Mexidol White (toothpaste)

The release form of the drug allows its use in dental practice. The tube contains 65 g of product. Indications for the use of Mexidol White include the presence of plaque and inflammatory gum diseases. Thanks to the components included in the composition, the drug provides gentle cleaning of teeth and prevents the re-formation of plaque. Mexidol White protects teeth from aggressive agents that cause caries. The active ingredient in toothpaste prevents gum bleeding and reduces the severity of inflammatory diseases. Contraindication for use is individual intolerance to the components of the drug.

MEXIDOL solution for intravenous and intramuscular administration 50 mg/ml ampoule 2 ml No. 10

IM or IV (stream or drip). When administered by infusion, the drug should be diluted in 0.9% sodium chloride solution. Mexidol® is administered in a stream slowly over 5–7 minutes, and dropwise at a rate of 40–60 drops per minute. The maximum daily dose should not exceed 1200 mg. For acute cerebrovascular accidents, Mexidol® is used in the first 10-14 days - 200-500 mg intravenously 2-4 times a day, then 200-250 mg intramuscularly 2-3 times a day for 2 weeks . For traumatic brain injury and the consequences of traumatic brain injury, Mexidol® is used for 10–15 days intravenously at a dose of 200–500 mg 2–4 times a day. For discirculatory encephalopathy in the decompensation phase, Mexidol® should be prescribed intravenously in a stream or drip at a dose of 200–500 mg 1–2 times a day for 14 days. Then IM 100–250 mg/day over the next 2 weeks. For a course of prophylaxis of discirculatory encephalopathy, the drug is administered intramuscularly at a dose of 200–250 mg 2 times a day for 10–14 days. For mild cognitive impairment in elderly patients and for anxiety disorders, the drug is used intramuscularly at a daily dose of 100–300 mg/day. for 14 – 30 days. In case of acute myocardial infarction, as part of complex therapy, Mexidol® is administered intravenously or intramuscularly for 14 days, against the background of traditional therapy for myocardial infarction, including nitrates, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, thrombolytics, anticoagulant and antiplatelet agents, as well as symptomatic means according to indications. In the first 5 days, to achieve maximum effect, it is advisable to administer the drug intravenously; in the next 9 days, Mexidol® can be administered intramuscularly. Intravenous administration of the drug is carried out by drip infusion, slowly (to avoid side effects) in a 0.9% sodium chloride solution or 5% dextrose (glucose) solution in a volume of 100 - 150 ml for 30 - 90 minutes. If necessary, a slow jet injection of the drug, lasting at least 5 minutes, is possible. The drug is administered (intravenous or intramuscular) 3 times a day, every 8 hours. The daily therapeutic dose is 6–9 mg/kg body weight per day, a single dose is 2–3 mg/kg body weight. The maximum daily dose should not exceed 800 mg, single dose - 250 mg. For open-angle glaucoma of various stages, as part of complex therapy, Mexidol® is administered intramuscularly at 100–300 mg/day, 1–3 times a day for 14 days. For alcohol withdrawal syndrome, Mexidol® is administered in a dose of 200–500 mg intravenously or intramuscularly 2–3 times a day for 5–7 days. In case of acute intoxication with antipsychotic drugs, the drug is administered intravenously at a dose of 200–500 mg/day for 7–14 days. In acute purulent-inflammatory processes of the abdominal cavity (acute necrotizing pancreatitis, peritonitis), the drug is prescribed on the first day both in the preoperative and postoperative periods. The administered doses depend on the form and severity of the disease, the prevalence of the process, and variants of the clinical course. The drug should be discontinued gradually only after a stable positive clinical and laboratory effect. For acute edematous (interstitial) pancreatitis, Mexidol® is prescribed 200–500 mg 3 times a day, intravenously (in 0.9% sodium chloride solution) and intramuscularly. Mild severity of necrotizing pancreatitis - 100 - 200 mg 3 times a day intravenously (in 0.9% sodium chloride solution) and intramuscularly. Moderate severity - 200 mg 3 times a day, intravenously (in 0.9% sodium chloride solution). Severe course - in a pulse dosage of 800 mg on the first day, with a two-fold administration regimen; then 200–500 mg 2 times a day with a gradual reduction in the daily dose. Extremely severe course - at an initial dosage of 800 mg/day until the manifestations of pancreatogenic shock are persistently relieved, after stabilization of the condition, 300 - 500 mg 2 times a day intravenously (in 0.9% sodium chloride solution) with a gradual decrease in the daily dosage.

Interaction

The drug is combined with many drugs used to treat somatic pathologies. Mexidol enhances the effect of antidepressants, anticonvulsants, antiparkinsonian, and benzodiazepine drugs. This allows you to reduce the initial dosage of prescribed medications.

Compatibility of Mexidol and Combilipen

In neurological practice, Mexidol and Combilipen are often prescribed for the treatment of various diseases. The drugs enhance each other’s effects, promoting rapid restoration of affected areas of the nervous system and improving tissue trophism. Combilipen is one of the vitamin-containing medicines. It contains B vitamins. The drug improves nerve conduction and helps normalize blood microcirculation. Vitamins and antioxidants are used to treat strokes, encephalopathies, polyneuropathies and other neurological diseases. The combined use of the drugs Combilipen and Mexidol normalizes emotional states and improves brain activity.

Compatibility of Mildronate and Mexidol

Mildronate has a general tonic effect on the body, eliminates the manifestations of hypoxia and restores damaged cells. The drug increases endurance. Indications for prescribing Mildronate include physical and psycho-emotional stress, the recovery period after surgery, treatment of alcohol dependence, and decreased performance. The simultaneous use of Mildronate and Mexidol is not contraindicated. Medicines are used as part of complex therapy for brain disorders.

Compatibility of Mexidol and Grandaxin

Grandaxin belongs to the group of anxiolytic drugs derived from benzodiazepines. Indicated in the presence of psycho-emotional disorders. For example, neuroses, mental disorders, withdrawal symptoms due to alcohol abuse, depression, menopause. Mexidol enhances the effect of benzodiazepines. Therefore, a dosage adjustment of Grandaxin may be required. This must be taken into account when prescribing these drugs simultaneously.

Compatibility of Mexidol and Eglonil

Eglonil belongs to the group of neuroleptics. Has an antipsychotic effect. The drug blocks dopamine receptors. Indicated in the presence of psychosis and schizophrenia. Taking Mexidol and Eglonil together can enhance the effect of the latter. This may require adjustment of the drug dose.

Mexidol dosage

IM or IV (stream or drip). When administered by infusion, the drug should be diluted in 0.9% sodium chloride solution.

Mexidol® is administered slowly over 5–7 minutes in a stream, and dropwise at a rate of 40–60 drops per minute. The maximum daily dose should not exceed 1200 mg.

For acute cerebrovascular accidents, Mexidol® is used in the first 10–14 days - 200–500 mg IV drip 2–4 times a day, then 200–250 mg IM 2–3 times a day for 2 weeks .

For traumatic brain injury and the consequences of traumatic brain injuries, Mexidol® is used for 10-15 days intravenously at a dose of 200–500 mg 2–4 times a day.

For dyscirculatory encephalopathy in the decompensation phase, Mexidol® should be prescribed intravenously in a stream or drip at a dose of 200–500 mg 1–2 times a day for 14 days. Then IM 100–250 mg/day over the next 2 weeks.

For a course of prophylaxis of discirculatory encephalopathy, the drug is administered intramuscularly at a dose of 200–250 mg 2 times a day for 10–14 days.

For mild cognitive impairment in elderly patients and anxiety disorders, the drug is used intramuscularly at a daily dose of 100–300 mg/day for 14–30 days.

In case of acute myocardial infarction, as part of complex therapy, Mexidol® is administered intravenously or intramuscularly for 14 days, against the background of traditional therapy for myocardial infarction, including nitrates, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, thrombolytics, anticoagulant and antiplatelet agents, as well as symptomatic means according to indications.

In the first 5 days, to achieve maximum effect, it is advisable to administer the drug intravenously; in the next 9 days, Mexidol® can be administered intramuscularly.

Intravenous administration of the drug is carried out by drip infusion, slowly (to avoid side effects) in a 0.9% sodium chloride solution or 5% dextrose (glucose) solution in a volume of 100–150 ml for 30–90 minutes. If necessary, a slow jet injection of the drug, lasting at least 5 minutes, is possible.

The drug is administered (intravenous or intramuscular) 3 times a day, every 8 hours. The daily therapeutic dose is 6-9 mg/kg body weight per day, a single dose is 2-3 mg/kg body weight. The maximum daily dose should not exceed 800 mg, single dose - 250 mg.

For open-angle glaucoma of various stages, as part of complex therapy, Mexidol® is administered intramuscularly at 100–300 mg/day, 1–3 times a day for 14 days.

For alcohol withdrawal syndrome, Mexidol® is administered in a dose of 200–500 mg intravenously or intramuscularly 2–3 times a day for 5–7 days.

In case of acute intoxication with antipsychotic drugs, the drug is administered intravenously at a dose of 200-500 mg/day for 7-14 days. In acute purulent-inflammatory processes of the abdominal cavity (acute necrotizing pancreatitis, peritonitis), the drug is prescribed on the first day both in the preoperative and postoperative periods. The administered doses depend on the form and severity of the disease, the prevalence of the process, and variants of the clinical course. The drug should be discontinued gradually only after a stable positive clinical and laboratory effect.

For acute edematous (interstitial) pancreatitis, Mexidol® is prescribed 200–500 mg 3 times a day, intravenously (in 0.9% sodium chloride solution) and intramuscularly. Mild severity of necrotizing pancreatitis - 100-200 mg 3 times a day intravenously (in 0.9% sodium chloride solution) and intramuscularly. Moderate severity - 200 mg 3 times a day intravenously (in 0.9% sodium chloride solution). Severe course - in a pulse dosage of 800 mg on the first day with a double dose regimen; then 200–500 mg 2 times a day with a gradual reduction in the daily dose. Extremely severe course - at an initial dosage of 800 mg/day until the manifestations of pancreatogenic shock are persistently relieved, after stabilization of the condition, 300-500 mg 2 times a day intravenously (in 0.9% sodium chloride solution) with a gradual decrease in the daily dosage.

Mexidol and alcohol

Mexidol is used to treat withdrawal symptoms associated with alcohol abuse. The drug helps normalize brain activity, improve blood circulation, and remove toxins from the body. Indications for the use of Mexidol are alcoholic encephalopathy, polyneuropathy, manifestations of withdrawal syndrome, epileptic seizures due to an overdose of alcoholic beverages, intoxication syndrome. Prescribing the drug to dependent people helps speed up the recovery period. Taking alcohol together with Mexidol leads to the fact that the drug does not have time to restore damaged cells. As a result, the effect of the drug is reduced to zero. Further use of the drug is pointless.

Mexidol

Mexidol® is administered intramuscularly or intravenously (stream or drip). To prepare a solution for infusion, the drug should be diluted in 0.9% sodium chloride solution.

Mexidol® is injected slowly over 5-7 minutes in a stream, and dropwise at a rate of 40-60 drops/min. The maximum daily dose should not exceed 1200 mg.

In case of acute cerebrovascular accidents, Mexidol® is used in the first 10-14 days intravenously at a dose of 200-500 mg 2-4 times a day, then intramuscularly at a dose of 200-250 mg 2-3 times a day for 2 weeks. .

For traumatic brain injury and the consequences of traumatic brain injury, Mexidol® is used for 10-15 days intravenously at a dose of 200-500 mg 2-4 times a day.

For dyscirculatory encephalopathy in the decompensation phase, Mexidol® is used intravenously in a stream or drip at a dose of 200-500 mg 1-2 times a day for 14 days, then intramuscularly at 100-250 mg/day for the next 2 weeks.

For course prevention of dyscirculatory encephalopathy, Mexidol® is administered intramuscularly at a dose of 200-250 mg 2 times a day for 10-14 days.

For mild cognitive impairment in elderly patients and anxiety disorders, Mexidol® is administered intramuscularly at a dose of 100-300 mg/day for 14-30 days.

In case of acute myocardial infarction, as part of complex therapy, Mexidol® is administered intravenously or intramuscularly for 14 days, against the background of traditional therapy for myocardial infarction, including nitrates, beta-blockers, ACE inhibitors, thrombolytics, anticoagulant and antiplatelet agents, as well as symptomatic means according to indications.

In the first 5 days, to achieve maximum effect, it is advisable to administer the drug intravenously; in the next 9 days, Mexidol® can be administered intramuscularly.

The drug is administered intravenously by drip infusion, slowly (to avoid side effects) in a 0.9% sodium chloride solution or a 5% dextrose (glucose) solution in a volume of 100-150 ml for 30-90 minutes. If necessary, a slow jet injection of the drug lasting at least 5 minutes is possible.

The drug is administered (IV or IM) 3 times a day every 8 hours. The daily therapeutic dose is 6-9 mg/kg body weight/day, a single dose is 2-3 mg/kg body weight. The maximum daily dose should not exceed 800 mg, single dose - 250 mg.

For open-angle glaucoma of various stages, as part of complex therapy, Mexidol® is administered intramuscularly at 100-300 mg/day 1-3 times/day for 14 days.

For alcohol withdrawal syndrome, Mexidol® is administered in a dose of 200-500 mg intravenously or intramuscularly 2-3 times a day for 5-7 days.

In case of acute intoxication with antipsychotic drugs, Mexidol® is administered intravenously at a dose of 200-500 mg/day for 7-14 days.

In acute purulent-inflammatory processes of the abdominal cavity (acute necrotizing pancreatitis, peritonitis), Mexidol® is prescribed on the first day both in the preoperative and postoperative periods. The administered doses depend on the form and severity of the disease, the prevalence of the process, and variants of the clinical course. Discontinuation of the drug should be done gradually, only after a stable positive clinical and laboratory effect.

For acute edematous (interstitial) pancreatitis, Mexidol® is prescribed 200-500 mg 3 times a day intravenously (in isotonic sodium chloride solution) and intramuscularly.

For necrotizing pancreatitis of mild severity, Mexidol® is prescribed 100-200 mg 3 times a day intravenously (in isotonic sodium chloride solution) and intramuscularly.

For necrotizing pancreatitis of moderate severity - 200 mg 3 times a day intravenously (in isotonic sodium chloride solution).

For severe necrotizing pancreatitis - in a pulse dosage of 800 mg on the first day, with a double dose regimen, then - 200-500 mg 2 times a day with a gradual reduction in the daily dose.

In an extremely severe form of necrotizing pancreatitis, the initial dose is 800 mg/day until the manifestations of pancreatogenic shock are persistently relieved, after stabilization of the condition - 300-500 mg 2 times a day intravenously (in 0.9% sodium chloride solution) with a gradual reduction in the daily dosage.

Overdose

In case of overdose, drowsiness may develop.

Comparison with other drugs

Analogs of Mexidol in terms of their effect include Mexiprim Astrox, Medomexi, Actovegin, Cerakson, Picamilon, Cavinton.

Mexidol or Mexiprim?

Mexiprim is one of the neuroprotectors. Available in tablet form and also as a solution for injection. The drug helps improve blood microcirculation, has a nootropic effect, and helps increase the body's resistance to psycho-emotional overload. Mexiprim is used to treat convulsive and withdrawal symptoms associated with alcohol abuse. Mexidol is the original drug, Mexiprim is a generic. According to research, Mexidol is absorbed more quickly into the gastrointestinal tract; its shell contains no preservatives or insoluble substances. Among the components of Mexiprim there is a preservative, the presence of which increases the possibility of developing individual intolerance to the drug.

Mexidol or Astrox?

Astrox is a generic version of the drug Mexidol. The drugs have the same active ingredient. Accordingly, the medications have identical effects. The difference between drugs lies in the manufacturing technology, excipients, release form and the quality of the purification of raw materials. These factors affect the bioavailability of the drug. Mexidol has a larger number of release forms. This variety allows you to select the required dosage depending on the disease and severity of the condition. The number of side effects of Astrox is significantly greater than that of Mexidol.

Mexidol or Medomexi?

Mexidol and Medomexi belong to the group of nootropic and antioxidant drugs. The action of the drugs is identical. The composition contains one active ingredient. Medomexi is an analogue of Mexidol. The difference between them lies in the total cost of the drug.

Mexidol or Actovegin?

Actovegin improves microcirculation of blood in the brain, accelerates healing processes, and increases the body's endurance in conditions of oxygen starvation. Actovegin is prescribed for cerebrovascular accidents, polyneuropathy, distal angiopathy due to diabetes mellitus. The drug promotes rapid tissue regeneration in wounds, abrasions and burns. Available in tablet form, as a solution for injection and ointments for external use. The differences between Mexidol and Actovegin lie in their mechanism of action. Unlike Mexidol, Actovegin has regenerating properties. Mexidol has a wider range of indications. Actovegin is approved for use during pregnancy and lactation. Often both drugs are prescribed as part of complex therapy for various diseases.

Mexidol or Ceraxon?

Ceraxon is one of the nootropic drugs. Used to treat acute cerebrovascular accident. The drug allows you to slow down the growth of the lesion for several hours. This time is enough to transport the patient to the hospital. Cerakson is prescribed during the rehabilitation period after a stroke, to normalize the condition after traumatic brain injury. Ceraxon and Mexidol are complementary drugs. They are used as part of complex therapy for brain disorders.

Mexidol or Picamilon?

Picamilon is a nootropic drug. Promotes the expansion of blood vessels in the brain. Indications for the use of the drug are cerebrovascular accident, withdrawal syndrome, encephalopathy of various origins, increased anxiety and irritability, severe migraine-type headaches. Unlike Mexidol, Picamilon is approved for use in school-age children. The medicine is used to increase brain activity.

Mexidol and Picamilon are complementary medicines. Their combined use improves the prognosis and speeds up the recovery period.

Mexidol or Cavinton?

Cavinton has antioxidant and antihypoxic effects and reduces the possibility of blood clots. Indicated as part of complex therapy for cerebrovascular accidents, encephalopathy of various origins, increased blood pressure, and pathology of the vestibular apparatus. The simultaneous use of Mexidol and Cavinton is not contraindicated. Medicines are considered complementary, but they should be taken at different times of the day.

Indications for use of Mexidol

acute cerebrovascular accidents;
traumatic brain injury, consequences of traumatic brain injury;
iscirculatory encephalopathy;
autonomic dystonia syndrome;
mild cognitive disorders of atherosclerotic origin;
anxiety disorders in neurotic and neurosis-like conditions;
acute myocardial infarction (from the first day) as part of complex therapy;
primary open-angle glaucoma of various stages, as part of complex therapy;
relief of withdrawal syndrome in alcoholism with a predominance of neurosis-like and vegetative-vascular disorders;
acute intoxication with antipsychotic drugs;
acute purulent-inflammatory processes of the abdominal cavity (acute necrotizing pancreatitis, peritonitis) as part of complex therapy.

Mexidol 50mg/ml 5ml 5 pcs. solution for intravenous and intramuscular administration

pharmachologic effect

Antioxidant agent.
Means for the correction of disorders in alcoholism, toxic and drug addiction.

Composition and release form Mexidol 50 mg/ml 5 ml 5 pcs. solution for intravenous and intramuscular administration

Active ingredient: ethylmethylhydroxypyridine succinate – 50 mg.
Excipients: sodium metabisulfite – 0.4 mg; water for injections up to 1 ml.

Solution for intravenous and intramuscular administration 50 mg/ml in colorless or light-protective glass ampoules with a blue break point or a white break point and three marking rings (top - yellow, middle - white, bottom - red) 2 ml or 5 ml . 5 ampoules in a blister pack. 1 or 2 blister packs along with instructions for medical use in a cardboard pack. 4, 10 or 20 blister packs along with instructions for medical use in a box of cardboard (for hospitals).

Description of the dosage form

Colorless or slightly yellowish transparent liquid in ampoules of 2 or 5 ml.